By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research
|
December 11, 2024
|
The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...
Coreena Robertson
|
November 18, 2024
|
Discover BioVaxys’ innovative DPX™ platform, a cutting-edge lipid-based delivery system transforming immunotherapy. This video explores how the company’s proprietary technology encapsulates diverse bioactive molecules, enhancing and sustai...
Research
|
October 8, 2024
|
The TSX experienced a dynamic week. It opened flat on Monday, but saw a significant jump on Tuesday, driven by a global increase in commodity prices following new monetary stimulus measures in China. However, the energy sector’s decline led to a breather...
Jonathon Brown
|
September 26, 2024
|
Daimler Truck must reduce forecasts It is a challenging time for transportation companies. By 2030, fleet operators in the EU will have to meet specific requirements to reduce CO2 emissions. The EU has introduced stricter CO2 standards for heavy-duty vehicles, requi...
Armin Schulz
|
August 12, 2024
|
The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...
Lyndsay Malchuk
|
July 30, 2024
|
As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...
Jonathon Brown
|
July 4, 2024
|
The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...
Jonathon Brown
|
June 20, 2024
|
Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
Stefan Feulner
|
May 22, 2024
|
This week, the North American stock markets managed to showcase some contrasted performances. While the NASDAQ and S&P 500 reached record highs, driven by optimism around potential Federal Reserve rate cuts, the Dow Jones also enjoyed a solid rally. Meanwhile, the TS...
Jonathon Brown
|
May 16, 2024
|